BioLife Solutions, Inc. (BLFS) — Analyst outlook / Analyst consensus target is. Based on 17 analyst ratings, the consensus is bullish — 17 Buy.
The consensus price target is $33.00 (low: $32.00, high: $34.00), representing an upside of 62.8% from the current price $20.27.
Analysts estimate Earnings Per Share (EPS) of $-0.47 and revenue of $0.11B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.44 vs est $-0.47 (beat +5.6%). 2025: actual $-0.25 vs est $-0.34 (beat +25.8%). Analyst accuracy: 80%.
BLFS Stock — 12-Month Price Forecast
$33.00
▲ +62.80% Upside
Average Price Target
Based on 17 Wall Street analysts offering 12-month price targets for BioLife Solutions, Inc., the average price target is $33.00, with a high forecast of $34.00, and a low forecast of $32.00.
The average price target represents a +62.80% change from the last price of $20.27.
Highest Price Target
$34.00
Average Price Target
$33.00
Lowest Price Target
$32.00
BLFS Analyst Ratings
Buy
Based on 17 analysts giving stock ratings to BioLife Solutions, Inc. in the past 3 months
EPS Estimates — BLFS
80%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.44
vs Est –$0.47
▲ 6.0% off
2025
Actual –$0.25
vs Est –$0.34
▲ 34.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — BLFS
86%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.082B
vs Est $0.105B
▼ 27.2% off
2025
Actual $0.096B
vs Est $0.096B
▲ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
